CD123 is highly expressed on 45–95% of AML cells (Du et al., 2007), while at low or negative level on primitive hematopoietic stem cells, erythroid progenitor cells, mature granulocytes and lymphocytes (Liu et al., 2015). Here, IL3RA is linked to acute myeloid leukemia.